While external ionizing radiation has been used for treating non-small cell lung cancer (NSCLC), improved efficacy of this modality would be an important advance. Ectopic expression of the sodium iodide symporter (NIS) and thyroperoxidase (TPO) genes in NSCLC cells facilitated concentration of iodide in NSCLC cells, which markedly induced apoptosis in vitro and in vivo. Preincubation of the NIS/TPO-modified NSCLC cells in iodide followed by ionizing radiation generates bystander tumoricidal effects and potently enhances tumor cell killing. This iodide-induced bystander effect is associated with enhanced gap junction intercellular communication (GJIC) activity and increased connexin-43 (Cx43) expression. Thus, iodide may serve as an enhancer to markedly improve the efficacy of radiation therapy in combined therapeutic modalities.
Introduction
Lung cancer remains the leading cause of cancer death in both men and women. Even when diagnosed at early stages, non-small cell lung cancer (NSCLC) has often begun to metastasize, leading to frequent systemic relapses and a poor prognosis. Development of more effective strategies is needed. Radiation therapy is commonly administered to approximately 50% of NSCLC patients with inoperable disease. In spite of limited clinical efficacy shown by radiation, normal tissue tolerance and inherent tumor radioresistance can hinder successful outcome. Therefore, there is still a need to achieve better efficacy and lower toxicity. In the last decade, new standards arose using combinations of radiation and other therapies given in different sequences at different doses. Research and clinical trials have demonstrated that in some settings combination treatment is often more effective than radiation therapy alone. [1] [2] [3] The ability to concentrate iodide is a fundamental property of the normally functioning thyroid gland and represents the first step in the synthesis of thyroid hormones. Sodium iodide symporter (NIS) plays a key role in this process by efficiently accumulating iodide from the circulation into the thyrocytes with sodium downgradient generated by the Na þ /K( þ )-ATPase. [4] [5] [6] [7] [8] [9] The NIS is an integral plasma membrane glycoprotein most commonly studied in connection with the thyroid, where NIS mediates the active transport of iodide into the thyroid follicular cells. The successful induction of NIS functional expression by gene transfer in extrathyroidal malignancies has been demonstrated in studies of the effects of radioiodide concentrator gene therapy in these tumors. [10] [11] [12] [13] [14] [15] However, enhanced iodide transport following transfer of the NIS gene is associated with reduced iodide retention as well as low absorbed dose, and therefore limits its tumoricidal efficacy. 15 To enhance tumor apoptosis, we introduced an iodide uptake and retention mechanism into NSCLC cells. 10, 11 Thyroperoxidase (TPO) mediates iodination of intracellular proteins, and therefore prevents rapid efflux of iodide. In vitro, a marked increase in 125 I uptake and retention in lung cancer cells expressing NIS/TPO correlated with a marked increase in radioactive iodide-induced apoptosis. A marked increase in intracellular nonradioactive iodide levels also led to greater than 95% apoptosis. In vivo, the NIS/TPO-transduced tumor xenografts effectively accumulated 125 I within the tumor. Administration of potassium iodide systemically resulted in significant reduction of NIS/TPO-modified tumor volume in vivo without significant adverse effects.
In addition to directly inducing apoptosis, iodide may have a role in combined therapeutic modalities. Thus, synergism in tumor cell killing by combined therapies could improve anticancer efficacy and reduce adverse effects associated with therapy. We hypothesize that in addition to directly inducing apoptosis, iodide-based therapy will sensitize cancer cells to ionizing radiation. In this study, we demonstrate for the first time that exposure of NIS/TPO-modified NSCLC cells to iodide augments sensitivity to ionizing radiation, thus potently enhancing tumor cell killing.
Materials and methods

Cell cuture
Human lung undifferentiated large cell carcinoma cell line H1299 was obtained from American Type Culture Collection (Rockville, MD). The cells were grown at 371C under an atmosphere of 5% CO 2 in air as monolayers in 25-cm 2 tissue culture flasks containing 5.0 ml of RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin/streptomycin solution and 2 mM glutamine (JRH Biosciences, Lenexa, KS).
Retroviral vector construction and the transduction of H1299 cells
Human NIS and TPO plasmid vectors were previously described. 10 Retroviral vectors pLHCX containing a hygromycin-selection marker and pLNCX containing a neomycin-selection marker were obtained from Clontech Laboratories, Inc. (Palo Alto, CA). The retroviral NIS and TPO vectors were constructed by the insertion of the NIS gene into the pLHCX and the TPO gene into the pLNCX vectors. After transfection to the PT-67 retroviral packaging cell line by a liposomal-mediated method (Effectene method, Qiagen Inc., Valencia, CA), the supernatants containing high titer of retroviruses expressing NIS or TPO were collected to transduce H1299 cells. Single clones of genetically modified H1299 cells were selected with appropriate antibiotic-resistant markers. The clones were further characterized to confirm the presence of functional NIS and TPO genes by RT-PCR and 125 I uptake assays. Two NIS/TPO-modified H1299 stably transduced cell clones, which increased iodide uptake up to 320-fold (H1299NT1) and 164-fold, respectively, (H1299NT2), were used for the current studies. Parental H1299 and H1299Ctr (H1299 cells transduced with the empty vector) were served as controls.
Clonogenic assays
Clonogenic assays were used to determine the sensitivity of three-dimensional spheroid cultures of NSCLC cells to radiation and radioenhancement by iodide. H1299Ctr, H1299NT1, and H1299NT2 cells were incubated in medium only or in medium containing KI (10 mM) for 24 h, followed by external gamma-radiation at 1 Gy using a Shepherd Mark I laboratory irradiator. Immediately thereafter, 1000 cells of each condition in triplicate were dissolved in 4 ml of RPMI1640 medium containing 10% FBS and 0.3% agarose. The cells were then plated on 60-mm agar plates covered with 4 ml RPMI1640 medium containing 10% FBS and 0.6% agarose. The spheroid formation in agar plates was monitored daily. When the individual colonies were clearly visible visually, the plates were stained with 0.1% crystal violet in methanol and colonies with 4500 cells of each plate were counted and photographed for documentation. Cell survival was estimated by scoring the number of viable colonies. To determine the bystander effects, cell density was increased to 10 000 cells per 60-mm culture plate (a 10-fold increase) to facilitate the contact among colonies. H1299NT1 and H1299NT2 cells were treated with or without KI (30 mM) for 24 h. In all, 5000 iodide-treated H1299NT1 or H1299NT2 cells were mixed with equal number of nonirradiated parental H1299 cells and plated on agar culture plates in triplicates. After incubation, colonies were scored by the same method.
Determination of gap junction intercellular communication (GJIC) activities by double dye transfer assays
The GJIC activities were determined by double dye transfer assays as previously described. 16 Briefly, parental H1299 were harvested in a single cell suspension by trypsinization and washed once with PBS supplemented with 10 mM glucose and 30 mM HEPES. 2 Â 10 6 parental H1299 cells were stained with the untransferable fluorescent dye PKH26 (Sigma-Aldrich Inc., St Louis, MO) at a concentration of 2 mM in a total volume of 2 ml for 2 min at 251C. The staining was terminated by adding 2 ml fetal calf serum (FCS). The cells were washed three times in PBS supplemented with 10 mM glucose and 30 mM HEPES to remove residual dye and the cell pellets were resuspended in RPMI1640 medium containing 10% FBS. In parallel experiments, 2 Â 10 5 H1299NT1 or H1299NT2 cells/well were plated in six-well culture plates. Following incubation in medium containing 10-30 mM KI for 24 h, the cell monolayer cultures were stained with the transferable dye calcein-AM (Molecular Probes, Eugene, OR) in situ at a concentration of 0.5 mM for 30 min at 251C, followed by washing five times in PBS supplemented with 10 mM glucose and 30 mM HEPES to remove residual dye. An aliquot of 2 Â 10 5 PKH26-labeled parental H1299 cells were added to each well of calcein AM-labeled H1299NT1 cells (2 Â 
Results
Iodide enhances the NIS/TPO-modified NSCLC cells to ionizing radiation
Previously we found that reactive oxygen species (ROS) play a critical role in iodide-induced apoptosis in NIS/ TPO-transduced NSCLC cells. 11 Since ionizing radiation also induces ROS formation, 17, 18 in preliminary studies, we tested the concept whether iodide could synergistically enhance cytotoxicity by ionizing radiation. Two NIS/ TPO-transduced stable NSCLC cell clones (H1299NT1 and H1299NT2) and the empty-vector-transduced H1299 cell clone serving as a control (H1299Ctr) were incubated in medium only or in medium containing KI (10 mM) for 24 h, followed by external g-radiation at 1 Gy. In all, 1000 viable cells of each condition in triplicate were seeded immediately in agar plates for colonogenic assays. Pretreatment of two H1299NIS/TPO cell clones with iodide followed by radiation at 1 Gy markedly reduced clonogenic survival, while 1 Gy radiation alone had no significant tumoricidal effect on H1299NT1 or H1299NT2 cells (data not shown). In contrast, the clonogenic survival of H1299Ctr cells was not significantly modified with or without either iodide, radiation, or iodide plus radiation treatment (data not shown).
To further determine the efficacy of iodide in enhancing NSCLC cells to ionizing radiation, we measured a full survival curve of NSCLC cells when the cells were preincubated in relatively low iodide concentrations (100 mM and 1 mM) prior to exposure to a clinical range of radiation (0-4 Gy). As shown in Figure 1 , both H1299Ctr (containing control vector) and H1299NT (NIS/TPO gene modified) cells are sensitized to ionizing radiation at a dose of 4 Gy (Po0.05 compared to cells without exposure to radiation). There is no difference in the sensitivity to radiation-induced cytotoxicity between H1299Ctr and H1299NT cells. In comparison, when both H1299Ctr and H1299NT cells were preincubated in relatively low concentrations of iodide (100 mM and 1 mM) for 24 h, ionizing radiation more effectively killed H1299NT cells in a dose range of 1-4 Gy Iodide-induced apoptosis in the NIS/TPO-modified NSCLC cells generates a bystander tumoricidal effect Apoptotic vesicles generated from apoptotic cancer cells and phagocytized by nearby viable cancer cells through cell-to-cell contact have been suggested as one pathway for generating the 'bystander effect'. In some settings the bystander effect generated by radioactive iodide ( 131 I) plays a significant role in tumor cell sterilization. 19 To test whether iodide-induced apoptosis in the NIS/ TPO-modified NSCLC cells could generate bystander tumoricidal effects, cell density was increased to facilitate the contact among colonies. This three-dimensional spheroid culture system would allow the transmission of signals or substances among cells within the same colony as well as colonies in close contact. A typical viable spheroid in an agar plate is shown in Figure 2a . H1299NT1 and H1299NT2 cells were incubated in medium alone or medium containing KI (30 mM) for 24 h. Following external gamma-radiation at 1 Gy, 5000 iodide-treated H1299NT1 or H1299NT2 cells were mixed with equal number of nonirradiated parental H1299 cells and plated on agar culture plates in triplicates. Clonogenic survival rates in the pure H1299NT1 and H1299NT2 populations were 32.9 and 64.4%, respectively, following KI treatment (Figure 2b ). Clonogenic survival rates following KI treatment in the mixed cultures of H1299NT1 plus parental H1299 cells or H1299NT2 plus parental H1299 cells (50-50% ratio) were similar to those demonstrated in the pure H1299NT1 and H1299NT2 cultures (44.3 and 61.3%, respectively) ( Figure 2b ). The mixture of H1299Ctr cells and parental H1299 cells (50-50% ratio) showed no significant bystander effect (data not shown). Thus, these results confirm our hypothesis, indicating that iodide-induced apoptosis generates bystander effects.
Iodide induces GJIC activity in the NIS/TPO-modified lung cancer cells Both ROS and GJIC have been implicated in radiationinduced 'bystander effects'. 20 We have demonstrated the importance of ROS in iodide-induced apoptosis. 11 In addition to ROS, GJIC also may play a role in iodideinduced bystander tumoricidal effects. The GJIC activities between the iodide-treated H1299NT1 cells and parental NSCLC cells were determined by double-dye transfer assays. H1299NT1 cells were incubated in medium alone or in medium containing various concentrations of KI (0-30 mM), while parental H1299 cells were maintained in culture without KI treatment. After 24 h incubation, H1299NT1 cells were labeled with the transferable fluorescent dye calcein-AM and parental H1299 cells were labeled with the untransferable fluorescent dye PKH26, respectively. The GJIC activities of H1299NT1 cells with or without KI treatment were determined by flow cytometry when the fluorescent dye calcein-AM was transferred from the H1299NT1 cells to the parental H1299 cells in a coculture system. In this system, PKH26-labeled parental H1299 cells were overlayed to the top of calcein-AM-labeled H1299NT1 cell monolayers in a 1:1 ratio and cocultivated for 4.5 h to allow cell-to-cell contact and dye transfer. Iodide markedly induced GJIC in a dose-dependent manner (Figure 3a-d) . In contrast, cocultures of H1299Ctr and parental H1299 cells showed no significant difference in the absence (E) or presence (F) of KI (30 mM). The current results are consistent with studies of others, 20 suggesting that GJIC may play a critical role in iodide-induced bystander tumoricidal effect. 
Iodide sensitizes NSCLC cells to radiation L Zhang et al
Iodide induces Cx43 expression in the NIS/TPOmodified NSCLC cells Cx43 is a major component of gap junction channels in human lung cells. 21 A decrease in GJIC activity has been documented in many human malignancies including lung cancer. 21 This may be a consequence of reduced expression of Cx43 and defects in signal transduction pathways that mediate Cx43 function. 21 To test whether iodideinduced GJIC activity in the NIS/TPO-modified NSCLC correlates with an increase in Cx43, H1299NT1 and H1299Ctr cells were incubated in medium alone or in medium containing 30 mM KI for 24 h. Cell lysates of each Iodide sensitizes NSCLC cells to radiation L Zhang et al condition were applied to Western blot analysis using specific monoclonal anti-Cx43 antibody. Anti-b-actin antibody was served as a control for equal loading. Iodide induced a 3.1-fold increase in Cx43 protein levels in H1299NT1 cells while the constitutive level of Cx43 remained unchanged in H1299Ctr cells in response to iodide treatment (Figure 4) . Thus, iodide-induced GJIC activity in the NIS/TPO-modified NSCLC cells may be due to an increase in Cx43.
Discussion
Lung cancer leads as the number one cause of cancer death in both men and women. 22, 23 The majority of NSCLC patients are not eligible for surgical resection. Unfortunately, less than 15% of all patients are candidates for curative surgical resection. 24 Ionizing radiation is one of the most commonly used and most efficacious cancer therapies. Radiation therapy has several advantages such as quantitative dosimetry, the relative lack of clonal evolution of resistance, and the absence of 'sanctuary sites'. While external ionizing radiation has been used for treating NSCLC, improved efficacy of this modality would be an important advance.
A combined gene therapy and radiation regimen is one approach currently being developed to improve the efficacy and lower toxicity of radiation therapy. Integration of a radiosensitizer in combined anticancer therapies makes it a potential strategy for use in treating advanced lung cancer. 25 We have shown that a therapeutic dose of nonradioactive iodide potently induces apoptosis in NIS/ TPO-genetically modified NSCLC cells in vitro and tumor xenografts in vivo.
11 In addition to directly inducing apoptosis, iodide may also play a role in sensitizing NSCLC cells to ionizing radiation. This hypothesis was based on previous observations which showed that iodide compounds such as KI sensitized cells to radiationinduced DNA damage. 26, 27 ROS are the initiators activating signal transduction pathways involving nuclear DNA damage-sensing mechanisms activated by ionizing radiation. 28 However, radiation-induced ROS formation is transient and renders apoptotic resistance of malignant cells to ionizing radiation. 17, 18 We have shown that iodide-induced apoptosis in the NIS/TPO-transduced NSCLC cells is ROS dependent.
11 Based on our previous work and studies of others, a combination of iodide and radiation may potently enhance the efficacy of radiation and overcome tumor resistance. Here we utilized threedimensional spheroid cultures to assess the iodide effect on the radiation sensitivity of genetically modified NSCLC cells. Pretreatment of the NIS/TPO-transduced NSCLC cells with iodide sensitizes them to ionizing radiation. Thus, iodide may serve as a potent radiation sensitizer to synergistically enhance tumor cell killing in combined gene and radiation therapy. Interestingly, KI (10 mM) significantly reduced clonogenic survival in H1299NT2 cells at 24 h incubation (Po0.05) while H1299NT1 cell clone appeared to be more resistant to iodide-induced apoptosis. The different sensitivities to iodide-induced apoptosis between H1299NT1 and H1299NT2 cell clones are possibly due to factors other than the levels of iodide uptake (320-fold versus 164-fold increase) may be the result of clone selection. However, further investigations will be required to define mechanisms underlying these differences.
Bystander effects in suicide gene therapy in cancer have been suggested to be directly proportional to the degree of GJIC. 29 'Bystander effects' are highly desirable in the development of cancer gene therapies because they may help to overcome one of the main limitations to gene therapy; no vector system is currently available that allows for consistent transduction of all malignant cells in a tumor mass. Carlin et al. 19 have reported that exposure of three-dimensional spheroid cultures of the NIStransfected tumor cells to 131 I lead to a 10-fold more reduction of clonogenic survival than the two-dimensional monolayer cultures. This increase in sensitivity to 131 I exposure is likely to be due to a bystander effect. Based on our results and studies of others, we hypothesized that bystander effects may play a role in the synergism of combined iodide-based gene therapy and radiation. To determine whether iodide-induced apoptosis in NIS/TPO-genetically modified NSCLC cells have the capacity to kill neighboring cancer cells, we have assessed Iodide sensitizes NSCLC cells to radiation L Zhang et al bystander tumoricidal effect in a mixed three-dimensional spheroid culture system. The NIS/TPO-transduced NSCLC cells were preincubated in medium containing KI and cocultivated with equal numbers of parental NSCLC cells for the determination of clonogenic survival. The results suggest that iodide induces bystander tumoricidal effect. Thus, the bystander effect may account for a portion of the observed anticancer synergism of combined iodide-based gene therapy and radiation. Gap junctions are membrane channels that permit the transfer of ions and small molecules between contiguous cells. It has been postulated that GJIC plays a key role in cellular communication and homeostasis in multicellular organisms. Phosphorylated GCV passes from HSV-tk gene-transduced cells to nontransduced neighboring cells via GJIC is one of the leading hypotheses to explain the bystander effect. 30, 31 Studies have shown that GJIC may progressively decrease during multistage carcinogenesis. 21 Interestingly, a low iodine diet inhibits GJIC in thyroid follicular cells. 32 In the current study, we tested whether GJIC might play a role in iodide-induced bystander tumoricidal effect by the double-dye transfer assays. This method allows for the detection of slow-and low-level GJIC activity, which is essential for NSCLC cells because lung cancer cells lack of the rapid-transfer type of GJIC activity. 16 In agreement with other investigators, our results show that iodide markedly induced GJIC in the NIS/TPO-modified NSCLC cells while iodide had no significant effect on GJIC activity in the H1299 cells transduced with the empty vector as a control.
Connexins are the proteins that form the GJIC channels. Cx43 is a major component of gap junction channels in many cell types including human lung cells. 21 Compared to normal lung epithelial cells, Cx43 expression is significantly lower in lung cancer cell lines. 33, 34 The Cx43-mediated GJIC pathway is implicated in the observed bystander effect in cancer gene therapy. 35 In parallel studies, iodide significantly induces the expression of Cx43, suggesting that Cx43 plays a critical role in iodide-induced GJIC activity in NIS/TPO-genetically modified NSCLC cells.
Studies have shown that GJIC propagates cell death in cancer cells. 36 The release of radiation-induced signal factors through GJIC was also suggested by other investigators. 20 Three-dimensional spheroid cultures are more sensitive to ionizing radiation than cell monolayers but that inhibition of GJIC can reverse the effects of contact. 37 In agreement with these early observations, our results indicate that GJIC plays a critical role in propagating apoptotic effects in the NIS/TPO-modified NSCLC cells by iodide. Currently, which iodide-induced key components are transferred through the gap junctions in the NIS/TPO-modified NSCLC cells remains unclear and requires further investigation. Potential candidates are small molecules including iodide, Ca 2 þ , ROS, or other indeterminate signal factors. 10, 11, 20, 32, 36 The prognosis for NSCLC patients remains poor, with a high percentage of patients presenting with advanced disease and metastases. Thus, the therapeutic goal is to provide optimal local control and to eradicate any metastases. The advent of novel therapies has provided new hope in the treatment of this disease. Clinical applications of genetic radiotherapy (gene therapy þ radiation therapy) for cancer require advances in gene delivery systems. The ultimate success of gene therapies will depend on gene transfer vectors that facilitate the expression of a specific gene at therapeutic levels in cancer cells without eliciting cytotoxicity in normal cells. We are currently evaluating a variety of new gene delivery systems for optimal gene delivery. While used as local therapy in combination with radiation, this novel iodidebased gene therapy could be combined with systemic therapy in an attempt to eradicate metastasis.
